Introducing Medisca Nutraceuticals

Download in electronic PDF format for $25



Search the Complete Journal Archives

PostScription: Experts Everywhere

Author(s):  Rahe Hank

Issue:  Mar/Apr 2005 - Health and Wellness
View All Articles in Issue

Abstract:  Recent articles by individuals associated with the Controlled Environmental Testing Association (CETA) offer recommendations for barrier isolators used in pharmacy compounding. These recommendations are based, however, on misinterpretations of US Food and Drug Administration (FDA) policy, confusing guidelines for manufacturing with guidelines for compounding. United States Pharmacopeia (USP) Chapter <797> is an enforceable standard for compounding sterile preparations, while FDA regulations govern drug manufacturing processes. Great care has been taken in the construction of USP Chapter <797> to separate the requirements of manufacturing from the pharmacist’s right to compound. Compounding under the definitions and requirements outlined in USP Chapter <797> provide a safe environment without adding the more stringent requirements of the manufacturing environment. Confusing the requirements, as in the CETA documents, not only creates confusion but also endangers the intended separation of manufacturing and compounding.

Related Keywords: Hank Rahe, BSIM, MSE, barrier isolators, cleanroom, United States Pharmacopeia, USP Chapter <797>, US Food and Drug Administration, FDA, airflow, sterile preparation

Related Categories: LEGAL, STERILE PREPARATIONS, UNITED STATES PHARMACOPEIA CONVENTIONS

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards Newton David W, Trissel Lawrence A Jul/Aug 2004 251 Buy
PostScription: Experts Everywhere Rahe Hank Mar/Apr 2005 167 Buy
Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations Okeke Claudia C Jul/Aug 2007 302-305 Buy
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Allen Loyd V Jr, Okeke Claudia C Sep/Oct 2007 404-410 Buy
Technology Spotlight: Barrier Isolators Moussa Magdy, Rahe Hank, Lo Katharine Jan/Feb 2003 42 Buy
Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists Rahe Hank Mar/Apr 2004 89 Buy
United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013 Newton David W Jul/Aug 2013 283-288 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards Kastango Eric S May/Jun 2008 216-229 Buy
Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations Newton David W Mar/Apr 2005 127-130 Buy